Related Experiment Videos
Biochemical mechanisms underlying MPTP-induced and idiopathic parkinsonism. New vistas
T P Singer1, R R Ramsay, P K Sonsalla
1Molecular Biology Division, Department of Veterans Affairs Medical Center, San Francisco, California 94121.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction.
British journal of pharmacology·2007
Variations in activity and inhibition with pH: the protonated amine is the substrate for monoamine oxidase, but uncharged inhibitors bind better.
Journal of neural transmission (Vienna, Austria : 1996)·2007
Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+).
Experimental neurology·2006
Monoamine oxidases: to inhibit or not to inhibit.
Mini reviews in medicinal chemistry·2003
Behavior therapy: other interventions for tic disorders.
Advances in neurology·2006
Treatment of aggression in Tourette syndrome.
Advances in neurology·2006
Treatment of co-morbid obsessive compulsive disorder, mood, and anxiety disorders.
Advances in neurology·2006
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs.
Advances in neurology·2006
Preclinical models relevant to Tourette syndrome.
Advances in neurology·2006
Corticosteroids, serum proteins, and the next phase of precision medicine in IgA nephropathy.
Clinical kidney journal·2026
The m6A regulatory network in plant stress adaptation: from mechanisms to breeding potential.
Frontiers in plant science·2026
Advances and applications of engineered protein therapeutics and their role in precision medicine.
Frontiers in bioengineering and biotechnology·2026
A Rare Homozygous Synonymous Variant in the ECM1 Gene in a Lipoid Proteinosis Patient.
Beyoglu eye journal·2026